Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 17, 2021

View Archived Issues

First preclinical data presented for chimeric fusion protein AT-03 in amyloidosis

The GABA aminotransferase inhibitor OV-329 shows anticonvulsant effects in two rat seizure models

ACE2-IgG4-Fc fusion protein neutralizes SARS-CoV-2, including several variants, at pM concentration

Targeting S100A7/RAGE signaling pathway inhibits breast tumorigenesis

Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders

TAXIS Pharmaceuticals divulges bacterial efflux pump inhibitors

Sanofi patents IL-17A/IL-17RA interaction inhibitors

Pfizer synthesizes new JAK1 inhibitors

Eli Lilly and Company presents new NTRK1 inhibitors

Proof of concept for novel NASH approach

Janssen discloses DHODH inhibitors

Researchers discover novel genes tied to classical Hodgkin's lymphoma predisposition

ELU-001 shows efficacy and safety in preclinical models of FRalpha-overexpressing cancers

Development of novel mouse model of Dravet syndrome

iECURE and Penn to develop next-generation LNPs for liver gene editing applications

Sosei and Twist collaborate to discover therapeutic antibodies against GPCR targets

Design of novel SSTR2 agonists for acromegaly

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...